1 Department of Pharmacology, Experimental Therapy and Toxicology and Interfaculty Center of Pharmacogenomics and Drug Research, University of Tübingen, 72074, Tübingen, Germany.
2 Institute of Pharmacology and Toxicology, University of Bonn, 53127, Bonn, Germany.
3 Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen (IDM), Tübingen, Germany.
4 German Center for Diabetes Research (DZD), Neuherberg, Germany; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen (IDM), Tübingen, Germany; Section on Experimental Radiology, Department of Diagnostic and Interventional Radiology, University of Tübingen, Germany.
5 Section on Experimental Radiology, Department of Diagnostic and Interventional Radiology, University of Tübingen, Germany.
6 Neurobiology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC, USA; Institute of Biomedical Research (BIOMED), Catholic University of Argentina, Buenos Aires, Argentina.
7 Department of Pharmacology, Experimental Therapy and Toxicology and Interfaculty Center of Pharmacogenomics and Drug Research, University of Tübingen, 72074, Tübingen, Germany. Electronic address: bernd.nuernberg@uni-tuebingen.de.